Legis Daily

Medicare Demonstration of Coverage for Low Vision Devices Act of 2019

USA116th CongressHR-4129| House 
| Updated: 7/31/2019
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (12)
Adam B. Schiff (Democratic)Frederica S. Wilson (Democratic)Steve Cohen (Democratic)Peter A. DeFazio (Democratic)Gus M. Bilirakis (Republican)Ann Wagner (Republican)Doris O. Matsui (Democratic)James A. Himes (Democratic)Cynthia Axne (Democratic)Julia Brownley (Democratic)Brian K. Fitzpatrick (Republican)Susan Wild (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicare Demonstration of Coverage for Low Vision Devices Act of 2019 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. The bill defines low-vision device to mean a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2020 and each of the next four fiscal years for the CMS to carry out the project.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 30, 2019
Introduced in House
Jul 30, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 30, 2019
Referred to the Subcommittee on Health.
Jul 31, 2019
Referred to the Subcommittee on Health.
  • July 30, 2019
    Introduced in House


  • July 30, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • July 30, 2019
    Referred to the Subcommittee on Health.


  • July 31, 2019
    Referred to the Subcommittee on Health.

Health

Congressional oversightGovernment studies and investigationsHealth care coverage and accessHealth technology, devices, suppliesHearing, speech, and vision careMedicare

Medicare Demonstration of Coverage for Low Vision Devices Act of 2019

USA116th CongressHR-4129| House 
| Updated: 7/31/2019
Medicare Demonstration of Coverage for Low Vision Devices Act of 2019 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. The bill defines low-vision device to mean a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2020 and each of the next four fiscal years for the CMS to carry out the project.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 30, 2019
Introduced in House
Jul 30, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 30, 2019
Referred to the Subcommittee on Health.
Jul 31, 2019
Referred to the Subcommittee on Health.
  • July 30, 2019
    Introduced in House


  • July 30, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • July 30, 2019
    Referred to the Subcommittee on Health.


  • July 31, 2019
    Referred to the Subcommittee on Health.
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (12)
Adam B. Schiff (Democratic)Frederica S. Wilson (Democratic)Steve Cohen (Democratic)Peter A. DeFazio (Democratic)Gus M. Bilirakis (Republican)Ann Wagner (Republican)Doris O. Matsui (Democratic)James A. Himes (Democratic)Cynthia Axne (Democratic)Julia Brownley (Democratic)Brian K. Fitzpatrick (Republican)Susan Wild (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightGovernment studies and investigationsHealth care coverage and accessHealth technology, devices, suppliesHearing, speech, and vision careMedicare